Related Experiment Video
Updated: Nov 28, 2025

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Continuous infusion factor replacement in haemophilia B during and after cardiac surgery: the better choice?
Saira Farid1, Sarah Sewaralthahab2, Hedy Patricia Smith3
1Internal Medicine, MedStar Georgetown Washington Hospital Center, Washington, DC, USA.
Abstract:
A 57-year-old man with mild haemophilia B was admitted for coronary artery bypass graft surgery. His factor IX (FIX) activity was 15% on admission. Our goal was to maintain his FIX activity at 80%-100% for post-op days (PODs) 0-3, and at 60%-80% for PODs 4-14. Preoperatively, the patient was given recombinant FIX (rFIX) bolus using the formula:Dosage needed=%(desired FIX level-current level of FIX)×weight (kg)×1.3.This increased his activity to 100%. One IU of rFIX increased FIX activity by 0.8%; the half-life of rFIX is 18-24 hours. The rFIX infusion was started intraoperatively and continued after surgery to maintain target FIX activity. He was discharged on POD 9 on rFIX bolus dosing of 5000 IU every 12 hours for an additional 5 days. Using continuous factor infusion, we managed to decrease the amount rFIX used by >60% while maintaining steady state FIX activity level.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Heart Failure VI: Adjunct Therapies
Venous Thrombosis III: Interprofessional Care
Continuous Renal Replacement Therapy
Cardiomyopathy VII: Pre and Post Operative Nursing Management

